Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Maintenance Therapy in HER2+ Metastatic Breast Cancer (MBC)Release Date:Education Oncology USA Efforts to Improve Quality of Migraine CareRelease Date:Partner: The Japanese Headache SocietyQuality Improvement Internal Medicine Japan Enhancing HCP Education in Adult Vaccination against Respiratory InfectionsRelease Date:Education Vaccines Austria, Belgium, Greece, Ireland, Luxembourg, Portugal, Switzerland Migraine and Women’s HealthQuality Improvement, Research Internal Medicine USA Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)Release Date:Research Rare Disease USA Real World Evidence on clinical outcomes with Aztreonam-Avibactam (ATM-AVI)Release Date:Research Inflammation & Immunology All Capacity Building for Clinical Trials in Sickle Cell Disease (SCD) - Education for Healthcare ProfessionalsRelease Date:Education Rare Disease USA Prostate Cancer: Best Practices for Combining Targeted Therapies in mPCRelease Date:Education Oncology USA Transthyretin Cardiac Amyloidosis FellowshipRelease Date:Research Rare Disease USA Optimizing Adult Vaccination Ecosystem in IndiaRelease Date:Quality Improvement Vaccines India Evidence Based Safety Contextualization of JAK inhibitors in the Treatment of Moderate to Severe Atopic DermatitisRelease Date:Education Inflammation & Immunology China, France, Germany, Italy, Japan, Korea, Spain, USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology Spain Title Grant Type Focus Area Country Application Due Date Hemophilia Research in Africa-Middle East, Asia Pacific, China and Latin AmericaRelease Date:Research Rare Disease All Rheumatic diseases such as SLE, SS, SSc, vasculitis syndromeRelease Date:Education Inflammation & Immunology Japan Optimal treatment and management of Rheumatoid ArthritisRelease Date:Education Inflammation & Immunology Japan Education relating to Etiology, diagnosis, treatment and, management of SpondyloarthritisRelease Date:Education Inflammation & Immunology Japan Inflammation ASPIRE Rheumatology: Europe (except Germany), Israel, Turkey, Russia, Australia, New Zealand, Japan and South KoreaRelease Date:Research Inflammation & Immunology All Inflammation ASPIRE Ulcerative Colitis:Europe (except Germany), Israel, Turkey,Russia,Australia,New Zealand, Japan, South KoreaRelease Date:Research Inflammation & Immunology All Raising Awareness and Promoting Timely Diagnosis of TTR AmyloidosisRelease Date:Quality Improvement Rare Disease All Hemophilia: Improve general knowledge level of gene therapyRelease Date:Education Rare Disease Japan Providing Enhanced Medical Support for Patients with Primary Immunodeficiency (PI) DisordersRelease Date:Education Internal Medicine USA Serotyping of Streptococcus pneumoniaeRelease Date:Education Vaccines Japan Artificial Intelligence/Machine Learning Research in HemophiliaRelease Date:Research Rare Disease USA Education of Healthcare Professionals to Provide Appropriate Medical Care for IBD PatientsRelease Date:Education Inflammation & Immunology Japan